Abstract:Introduction: The alarmin IL-33 has been implicated in the pathology of immune-mediated liver diseases. IL-33 activates regulatory T cells (Tregs) and type 2 innate lymphoid cells (ILC2s) expressing the IL-33 receptor ST2. We have previously shown that endogenous IL-33/ST2 signaling activates ILC2s that aggravate liver injury in murine immune-mediated hepatitis. However, treatment of mice with exogenous IL-33 before induction of hepatitis ameliorated disease severity. Since IL-33 induces expression of amphiregulin (AREG) crucial for Treg function, we investigated the immunoregulatory role of the ST2 + Treg/AREG axis in immune-mediated hepatitis. Methods: C57BL/6, ST2-deficient (Il1rl1 -/- ) and Areg -/- mice received concanavalin A to induce immune-mediated hepatitis. Foxp3Cre + x ST2fl/fl mice were pre-treated with IL-33 before induction of immune-mediated hepatitis. Treg function was assessed by adoptive transfer experiments and suppression assays. The effects of AREG and IL-33 on ST2 + Tregs and ILC2s were investigated in vitro . Immune cell phenotype was analyzed by flow cytometry. Results and discussion: We identified IL-33-responsive ST2 + Tregs as an effector Treg subset in the murine liver, which was highly activated in immune-mediated hepatitis. Lack of endogenous IL-33 signaling in Il1rl1 -/- mice aggravated disease pathology. This was associated with reduced Treg activation. Adoptive transfer of exogenous IL-33-activated ST2 + Tregs before induction of hepatitis suppressed inflammatory T-cell responses and ameliorated disease pathology. We further showed increased expression of AREG by hepatic ST2 + Tregs and ILC2s in immune-mediated hepatitis. Areg -/- mice developed more severe liver injury, which was associated with enhanced ILC2 activation and less ST2 + Tregs in the inflamed liver. Exogenous AREG suppressed ILC2 cytokine expression and enhanced ST2 + Treg activation in vitro . In addition, Tregs from Areg -/- mice were impaired in their capacity to suppress CD4 + T-cell activation in vitro . Moreover, application of exogenous IL-33 before disease induction did not protect Foxp3Cre + x ST2fl/fl mice lacking ST2 + Tregs from immune-mediated hepatitis. In summary, we describe an immunoregulatory role of the ST2 + Treg/AREG axis in immune-mediated hepatitis, in which AREG suppresses the activation of hepatic ILC2s while maintaining ST2 + Tregs and reinforcing their immunosuppressive capacity in liver inflammation.

The ST2+ Treg/amphiregulin axis protects from immune-mediated hepatitis

Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice

Blockade Of Il-33 Ameliorates Con A-Induced Hepatic Injury By Reducing Nkt Cell Activation And Ifn-Gamma Production In Mice

CD8+ T cell/IL-33/ILC2 axis exacerbates the liver injury in Con A-induced hepatitis in T cell-transferred Rag2-deficient mice

Suppression of Tumorigenicity 2 (st2) Signaling is Required for Regulatory T Cell Control of Graft-Vs. Host Disease

IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages.

The IL-33-ST2-MyD88 Axis Promotes Regulatory T Cell Proliferation in the Murine Liver

Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells

ST2+ T-regulatory Cells in Renal Inflammation and Fibrosis following Ischemic Kidney Injury

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunity

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

CD4+CD25+ Foxp3+ Regulatory T Cells Protect Against T Cell-Mediated Fulminant Hepatitis in a TGF-β-Dependent Manner in Mice

Interleukin 22 (Il-22) Plays A Protective Role In T Cell-Mediated Murine Hepatitis: Il-22 Is A Survival Factor For Hepatocytes Via Stat3 Activation

IL-33/ST2 Axis Deficiency Exacerbates Hepatic Pathology by Regulating Treg and Th17 Cells in Murine Schistosomiasis Japonica

Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.

Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis

Crucial Role of Il-4/Stat6 in T Cell-Mediated Hepatitis: Up-Regulating Eotaxins and Il-5 and Recruiting Leukocytes

Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury

Interleukin-6 Induces Gr-1+Cd11b+Myeloid Cells To Suppress Cd8+T Cell-Mediated Liver Injury In Mice

Myeloid Stat3 Inhibits T Cell-Mediated Hepatitis by Regulating T Helper 1 Cytokine and Interleukin-17 Production